Narcolepsy Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight | Key Companies - Jazz Pharmaceuticals, Takeda, Alza Corporation, Suven Life Sciences Ltd, Cephalon, Teva Pharmaceutical, Axsome Ther

DelveInsight's "Narcolepsy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Narcolepsy, historical and forecasted epidemiology as well as the Narcolepsy market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Narcolepsy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Narcolepsy Market Forecast
https://www.delveinsight.com/report-store/narcolepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Narcolepsy Market Report:
• The Narcolepsy market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In the United States, narcolepsy is thought to afflict 1 in every 2,000 persons, according to the Narcolepsy Network Organisation. Compared to paediatrics, adults are more often than children to experience narcolepsy, a sleep disease that is underdiagnosed
• Slowik et al. (2022) estimate that the prevalence of narcolepsy type 1 is 14 per 100,000 people and type 2 is 65.4 per 100,000. According to research from 2008 to 2010, it is most common in those who are in their late teens or early twenties, with a 50% larger female preponderance
• Imanishi et al. (2022) in a Japanese study, which employed a health insurance claims database, found that in 2010 and 2019, the overall yearly prevalence climbed from 5.7 to 18.5/100,000 people
• Key Narcolepsy Companies: Avadel Pharmaceuticals, Suven Life Sciences, NLS Pharmaceuticals, Taisho Pharmaceutical Co., Ltd., Jazz Pharmaceuticals, Takeda, Alza Corporation, Suven Life Sciences Ltd, Cephalon, Teva Pharmaceutical, Axsome Therapeutics, Inc., Orphan Medical, NLS Pharmaceutics, Avadel, and others
• Key Narcolepsy Therapies: LUMRYZ (FT218), Samelisant (SUVN-G3031), QUILIENCE (mazindol), TS-091, JZP-258, TAK-861, JNJ-17216498, SUVN-G3031, Xyrem, Modafinil, JZP-110, Armodafinil, AXS-12 (Reboxetine), sodium oxybate, mazindol extended release, FT218, and others
• The Narcolepsy epidemiology based on gender analyzed that females are more affected with narcolepsy (type1) than males
• The Narcolepsy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Narcolepsy pipeline products will significantly revolutionize the Narcolepsy market dynamics.

Narcolepsy Overview
The chronic neurological/brain disorder narcolepsy causes impaired sleep and awake regulation.An excessive amount of daytime sleepiness and abrupt, uncontrollable episodes of falling asleep at any time of the day are symptoms of narcolepsy. Although the exact aetiology of narcolepsy is unknown, research indicates that a number of factors, including autoimmune illnesses, family history, and brain traumas, among others, may contribute to the condition.

Get a Free sample for the Narcolepsy Market Report
https://www.delveinsight.com/sample-request/narcolepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Narcolepsy Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Narcolepsy Epidemiology Segmentation:
The Narcolepsy market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Narcolepsy
• Prevalent Cases of Narcolepsy by severity
• Gender-specific Prevalence of Narcolepsy
• Diagnosed Cases of Episodic and Chronic Narcolepsy

Download the report to understand which factors are driving Narcolepsy epidemiology trends @ Narcolepsy Epidemiology Forecast
https://www.delveinsight.com/sample-request/narcolepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Narcolepsy Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Narcolepsy market or expected to get launched during the study period. The analysis covers Narcolepsy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Narcolepsy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Narcolepsy Therapies and Key Companies
• LUMRYZ (FT218): Avadel Pharmaceuticals
• Samelisant (SUVN-G3031): Suven Life Sciences
• QUILIENCE (mazindol): NLS Pharmaceuticals
• TS-091: Taisho Pharmaceutical Co., Ltd.
• JZP-258: Jazz Pharmaceuticals
• TAK-861: Takeda
• JNJ-17216498: Alza Corporation
• SUVN-G3031: Suven Life Sciences Ltd.
• Xyrem: Jazz Pharmaceuticals
• Modafinil: Cephalon
• JZP-110: Jazz Pharmaceuticals
• Armodafinil: Teva Pharmaceutical
• AXS-12 (Reboxetine): Axsome Therapeutics, Inc.
• sodium oxybate: Orphan Medical
• mazindol extended release: NLS Pharmaceutics
• FT218: Avadel

Discover more about therapies set to grab major Narcolepsy market share @ Narcolepsy Treatment Market
https://www.delveinsight.com/sample-request/narcolepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Narcolepsy Market Strengths
• Many pharmaceutical companies are continuously researching and innovating the treatment regimens for eradicating the current unmet needs in narcolepsy
• The increasing prevalence of narcolepsy, for instance, knee pain associated with osteoarthritis, is primarily contributed by the increase in the aging population that will likely impact the market in the near future

Narcolepsy Market Opportunities
• Identify potential therapeutic targets and strategies for improving quality of life, and restore functional levels of those who suffer from Narcolepsy
• To understand the transition from acute to narcolepsy, how peripheral and central sensitization is manifested, and how they can be assessed

Scope of the Narcolepsy Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Narcolepsy Companies: Avadel Pharmaceuticals, Suven Life Sciences, NLS Pharmaceuticals, Taisho Pharmaceutical Co., Ltd., Jazz Pharmaceuticals, Takeda, Alza Corporation, Suven Life Sciences Ltd, Cephalon, Teva Pharmaceutical, Axsome Therapeutics, Inc., Orphan Medical, NLS Pharmaceutics, Avadel, and others
• Key Narcolepsy Therapies: LUMRYZ (FT218), Samelisant (SUVN-G3031), QUILIENCE (mazindol), TS-091, JZP-258, TAK-861, JNJ-17216498, SUVN-G3031, Xyrem, Modafinil, JZP-110, Armodafinil, AXS-12 (Reboxetine), sodium oxybate, mazindol extended release, FT218, and others
• Narcolepsy Therapeutic Assessment: Narcolepsy current marketed and Narcolepsy emerging therapies
• Narcolepsy Market Dynamics: Narcolepsy market drivers and Narcolepsy market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Narcolepsy Unmet Needs, KOL's views, Analyst's views, Narcolepsy Market Access and Reimbursement

To know more about Narcolepsy companies working in the treatment market, visit @ Narcolepsy Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/narcolepsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Narcolepsy Market Report Introduction
2. Executive Summary for Narcolepsy
3. SWOT analysis of Narcolepsy
4. Narcolepsy Patient Share (%) Overview at a Glance
5. Narcolepsy Market Overview at a Glance
6. Narcolepsy Disease Background and Overview
7. Narcolepsy Epidemiology and Patient Population
8. Country-Specific Patient Population of Narcolepsy
9. Narcolepsy Current Treatment and Medical Practices
10. Narcolepsy Unmet Needs
11. Narcolepsy Emerging Therapies
12. Narcolepsy Market Outlook
13. Country-Wise Narcolepsy Market Analysis (2019-2032)
14. Narcolepsy Market Access and Reimbursement of Therapies
15. Narcolepsy Market Drivers
16. Narcolepsy Market Barriers
17. Narcolepsy Appendix
18. Narcolepsy Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Narcolepsy Pipeline https://www.delveinsight.com/report-store/narcolepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Narcolepsy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Narcolepsy market. A detailed picture of the Narcolepsy pipeline landscape is provided, which includes the disease overview and Narcolepsy treatment guidelines.
Narcolepsy Epidemiology
https://www.delveinsight.com/report-store/narcolepsy-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Narcolepsy Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Narcolepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.